| Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway M Maeda, H Moro, T Ushijima Gastric Cancer 20, 8-15, 2017 | 107 | 2017 |
| Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues S Yamashita, T Kishino, T Takahashi, T Shimazu, H Charvat, Y Kakugawa, ... Proceedings of the national academy of sciences 115 (6), 1328-1333, 2018 | 86 | 2018 |
| Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3 M Maeda, H Takeshima, N Iida, N Hattori, S Yamashita, H Moro, ... Gut 69 (2), 243-251, 2020 | 61 | 2020 |
| High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study M Maeda, T Nakajima, I Oda, T Shimazu, N Yamamichi, T Maekita, ... Gut 66 (9), 1721-1723, 2017 | 61 | 2017 |
| Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication M Maeda, S Yamashita, T Shimazu, N Iida, H Takeshima, T Nakajima, ... Gastric Cancer 21, 745-755, 2018 | 43 | 2018 |
| Establishment of a DNA methylation marker to evaluate cancer cell fraction in gastric cancer L Zong, N Hattori, Y Yoda, S Yamashita, H Takeshima, T Takahashi, ... Gastric cancer 19, 361-369, 2016 | 26 | 2016 |
| Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways H Moro, N Hattori, Y Nakamura, K Kimura, T Imai, M Maeda, M Yashiro, ... Gastric Cancer 23, 105-115, 2020 | 24 | 2020 |
| Feasibility of laparoscopic gastrectomy for elderly gastric cancer patients: meta-analysis of non-randomized controlled studies L Zong, A Wu, W Wang, J Deng, S Aikou, H Yamashita, M Maeda, M Abe, ... Oncotarget 8 (31), 51878, 2017 | 21 | 2017 |
| Mandatory palliative care education for surgical residents: initial focus on teaching pain management H Oya, M Matoba, S Murakami, T Ohshiro, T Kishino, Y Satoh, ... Japanese Journal of Clinical Oncology 43 (2), 170-175, 2013 | 21 | 2013 |
| Risk stratification for gastric cancer after Helicobacter pylori eradication: A population‐based study on Matsu Islands TH Chiang, M Maeda, H Yamada, CC Chan, SLS Chen, SYH Chiu, ... Journal of Gastroenterology and Hepatology 36 (3), 671-679, 2021 | 18 | 2021 |
| SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation Y Yasukawa, N Hattori, N Iida, H Takeshima, M Maeda, T Kiyono, ... Carcinogenesis 42 (2), 180-189, 2021 | 17 | 2021 |
| RHOA mutation may be associated with diffuse-type gastric cancer progression, but is it gain or loss? M Maeda, T Ushijima Gastric Cancer 19, 326-328, 2016 | 12 | 2016 |
| DNA methylation genome-wide analysis in remnant and primary gastric cancers K Sugimoto, T Ito, A Hulbert, C Chen, H Orita, M Maeda, H Moro, ... Gastric Cancer 22, 1109-1120, 2019 | 9 | 2019 |
| A novel method to quantify base substitution mutations at the 10− 6 per bp level in DNA samples S Yamashita, N Iida, H Takeshima, N Hattori, M Maeda, T Kishino, ... Cancer letters 403, 152-158, 2017 | 9 | 2017 |
| Epigenetic Alterations in Gastrointestinal Cancers: Diagnostic and Therapeutic Applications T Ushijima, M Maeda, A Kawachi Gan to Kagaku ryoho. Cancer & Chemotherapy 45 (1), 1-7, 2018 | 2 | 2018 |
| Gastric Cancer Risk Prediction Using Epigenetic Alterations Accumulated in Noncancerous Gastric Tissues M Maeda, H Yamada, H Moro, T Ushijima Gastric Cancer: With Special Focus on Studies from Japan, 87-98, 2019 | 1 | 2019 |
